These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22586652)

  • 1. Curing "incurable" cancer.
    Watson JD
    Cancer Discov; 2011 Nov; 1(6):477-80. PubMed ID: 22586652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking cancer with RNA interference moves toward the clinic.
    Hede K
    J Natl Cancer Inst; 2005 May; 97(9):626-8. PubMed ID: 15870429
    [No Abstract]   [Full Text] [Related]  

  • 3. Target validation using RNA interference in solid tumors.
    Aharinejad S; Sioud M; Lucas T; Abraham D
    Methods Mol Biol; 2007; 361():227-38. PubMed ID: 17172715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of transcription factors as agents and targets for drug development.
    Smith LM; Birrer MJ
    Oncology (Williston Park); 1996 Oct; 10(10):1532-8; discussion 1541-2. PubMed ID: 8905845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights on oxidative stress in cancer.
    Visconti R; Grieco D
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):240-5. PubMed ID: 19333869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From correlation to causality: microarrays, cancer, and cancer treatment.
    O'Neill GM; Catchpoole DR; Golemis EA
    Biotechniques; 2003 Mar; Suppl():64-71. PubMed ID: 12664688
    [No Abstract]   [Full Text] [Related]  

  • 7. A gene expression database for the molecular pharmacology of cancer.
    Scherf U; Ross DT; Waltham M; Smith LH; Lee JK; Tanabe L; Kohn KW; Reinhold WC; Myers TG; Andrews DT; Scudiero DA; Eisen MB; Sausville EA; Pommier Y; Botstein D; Brown PO; Weinstein JN
    Nat Genet; 2000 Mar; 24(3):236-44. PubMed ID: 10700175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Myc oncoprotein as a therapeutic target for human cancer.
    Vita M; Henriksson M
    Semin Cancer Biol; 2006 Aug; 16(4):318-30. PubMed ID: 16934487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference screening for the discovery of oncology targets.
    Quon K; Kassner PD
    Expert Opin Ther Targets; 2009 Sep; 13(9):1027-35. PubMed ID: 19650760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial overview: cancer: from target discovery to targeted therapy: the risky business of target validation.
    Cruzalegui F
    Curr Opin Pharmacol; 2014 Aug; 17():iv-vi. PubMed ID: 25220882
    [No Abstract]   [Full Text] [Related]  

  • 11. Heat shock proteins in cancer: targeting the 'chaperones'.
    Nahleh Z; Tfayli A; Najm A; El Sayed A; Nahle Z
    Future Med Chem; 2012 May; 4(7):927-35. PubMed ID: 22571616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of telomerase and survivin as anticancer therapeutic targets using ribozymes and small-interfering RNAs.
    Zaffaroni N; Pennati M; Folini M
    Methods Mol Biol; 2007; 361():239-63. PubMed ID: 17172716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug transporters as targets for cancer chemotherapy.
    Nakanishi T
    Cancer Genomics Proteomics; 2007; 4(3):241-54. PubMed ID: 17878527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Normal' genes key to cancer growth.
    Check Hayden E
    Nature; 2008 Feb; 451(7179):615. PubMed ID: 18256629
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer Cell Line Encyclopedia launched by Novartis and Broad Institute.
    Marum L
    Future Med Chem; 2012 May; 4(8):947. PubMed ID: 22826900
    [No Abstract]   [Full Text] [Related]  

  • 16. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes.
    Levine AJ; Puzio-Kuter AM
    Science; 2010 Dec; 330(6009):1340-4. PubMed ID: 21127244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction to resistance to anticancer agents.
    Kruh GD
    Oncogene; 2003 Oct; 22(47):7262-4. PubMed ID: 14576836
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer stem cells: a step toward the cure.
    Boman BM; Wicha MS
    J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of apoptosis-associated genes by histone deacetylase inhibitors: implications in cancer therapy.
    Jazirehi AR
    Anticancer Drugs; 2010 Oct; 21(9):805-13. PubMed ID: 20679890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.